Ependymoma epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(13 intermediate revisions by 3 users not shown)
Line 2: Line 2:
{{Ependymoma}}
{{Ependymoma}}


{{CMG}}
{{CMG}} {{AE}} {{AAM}}


==Overview==
==Overview==
Ependymomas accounts for about 5% of adult intracranial [[gliomas]] and about 9% of childhood tumors of the central nervous system (CNS).
The incidence of ependymoma is approximately 0.05 to 0.08 per 100,000 individuals in the United States.<ref name="cancergov">National Cancer Institute. Physician Data Query Database 2015. http://www.cancer.gov/publications/pdq</ref> The posterior fossa tumours tend to present more commonly in the paediatric age group (mean age at diagnosis is 6 years of age). Male and female are affected equally by ependymomal tumors.


==Epidemiology and Demographics==
==Epidemiology and Demographics==
===Incidence===
===Incidence===
* Childhood Ependymoma represents about 200 cases per year in the United States<ref name="cancergov">National Cancer Institute. Physician Data Query Database 2015. http://www.cancer.gov/publications/pdq</ref>.
*The incidence of ependymoma is approximately 0.05 to 0.08 per 100,000 individuals in the United States.<ref name="cancergov">National Cancer Institute. Physician Data Query Database 2015. http://www.cancer.gov/publications/pdq</ref>
 
===Age===
===Age===
* Their occurrence seems to peak at age 5 years and then again at age 35.
* The posterior fossa tumors tend to present more commonly among the paediatric age group (mean age at diagnosis is 6 years of age).
* Subependymoma usually affects people over 40 years of age.
* Subependymoma usually affects people older than 40 years of age.


===Gender===
===Gender===
*Males and females are affected equally by ependymomal tumors.
* Subependymoma more often affects men than women.
* Subependymoma more often affects men than women.


==References==
==References==
{{reflist|2}}
{{reflist|2}}
[[Category:Disease]]
[[Category:Types of cancer]]
[[Category:Rare diseases]]
[[Category:Needs content]]
[[Category:Neurology]]


{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}
[[Category:Up-To-Date]]
[[Category:Oncology]]
[[Category:Medicine]]
[[Category:Neurosurgery]]

Latest revision as of 18:02, 20 September 2019

Ependymoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Epidemiology and Demographics

Risk Factors

Differentiating Ependymoma from other Diseases

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Staging

Laboratory Findings

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Ependymoma epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Ependymoma epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Ependymoma epidemiology and demographics

CDC on Ependymoma epidemiology and demographics

Ependymoma epidemiology and demographics in the news

Blogs on Ependymoma epidemiology and demographics

Directions to Hospitals Treating Ependymoma

Risk calculators and risk factors for Ependymoma epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Ahmad Al Maradni, M.D. [2]

Overview

The incidence of ependymoma is approximately 0.05 to 0.08 per 100,000 individuals in the United States.[1] The posterior fossa tumours tend to present more commonly in the paediatric age group (mean age at diagnosis is 6 years of age). Male and female are affected equally by ependymomal tumors.

Epidemiology and Demographics

Incidence

  • The incidence of ependymoma is approximately 0.05 to 0.08 per 100,000 individuals in the United States.[1]

Age

  • The posterior fossa tumors tend to present more commonly among the paediatric age group (mean age at diagnosis is 6 years of age).
  • Subependymoma usually affects people older than 40 years of age.

Gender

  • Males and females are affected equally by ependymomal tumors.
  • Subependymoma more often affects men than women.

References

  1. 1.0 1.1 National Cancer Institute. Physician Data Query Database 2015. http://www.cancer.gov/publications/pdq


Template:WikiDoc Sources